Literature DB >> 7471827

Life-threatening cold and exercise-induced asthma potentiated by administration of propranolol.

S Schwartz, S Davies, J A Juers.   

Abstract

We present two patients with acute respiratory failure secondary to cold and exercise-induced asthma. Neither patient had a prior history of asthma, and both had recently been placed on therapy with propranolol for treatment of hypertension. We discuss the postulated mechanism of bronchospasm in these patients. In addition, we urge aggressive searching for any change in respiratory symptoms in patients receiving propranolol.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7471827     DOI: 10.1378/chest.78.1.100

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Distribution of beta 1- and beta 2-adrenoceptors in mouse trachea and lung: a quantitative autoradiographic study.

Authors:  P J Henry; P J Rigby; R G Goldie
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

2.  Influence of intrinsic sympathomimetic activity on respiratory function during chronic beta blockade: comparison of propranolol and pindolol.

Authors:  R J Northcote; D Ballantyne
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

Review 3.  Status asthmaticus in adults.

Authors:  H Don
Journal:  Clin Rev Allergy       Date:  1985-02

4.  Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade.

Authors:  H W Clague; D Ahmad; S G Carruthers
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Plasma histamine concentration during propranolol induced bronchoconstriction.

Authors:  P W Ind; P J Barnes; M J Brown; C T Dollery
Journal:  Thorax       Date:  1985-12       Impact factor: 9.139

6.  Novel selective β1-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease.

Authors:  Jillian G Baker; Sheila M Gardiner; Jeanette Woolard; Christophe Fromont; Gopal P Jadhav; Shailesh N Mistry; Kevin S J Thompson; Barrie Kellam; Stephen J Hill; Peter M Fischer
Journal:  FASEB J       Date:  2017-04-11       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.